Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
Batista R, Vinagre J, Prazeres H, Sampaio C, Peralta P, Conceição P, Sismeiro A, Leão R, Gomes A, Furriel F, Oliveira C, Torres JN, Eufrásio P, Azinhais P, Almeida F, Gonzalez ER, Bidovanets B, Ecke T, Stinjs P, Pascual ÁS, Abdelmalek R, Villafruela A, Beardo-Villar P, Fidalgo N, Öztürk H, Gonzalez-Enguita C, Monzo J, Lopes T, Álvarez-Maestro M, Servan PP, De La Cruz SMP, Perez MPS, Máximo V, Soares P. Batista R, et al. Front Genet. 2019 Dec 18;10:1237. doi: 10.3389/fgene.2019.01237. eCollection 2019. Front Genet. 2019. PMID: 31921291 Free PMC article.
Precave: Immediate neoadjuvant instillation of chemotherapy for the prevention of non-muscle invasive bladder carcinoma recurrence: A prospective randomized clinical trial protocol.
Carrion DM, Gómez Rivas J, Ballesteros Ruiz C, Alvarez-Maestro M, Aguilera Bazán A, Martínez-Piñeiro L. Carrion DM, et al. Int J Surg Protoc. 2020 Oct 17;24:21-26. doi: 10.1016/j.isjp.2020.10.001. eCollection 2020. Int J Surg Protoc. 2020. PMID: 33195885 Free PMC article.
CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients.
Castellano E, Samba C, Esteso G, Simpson L, Vendrame E, García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Linares A, Leibar A, Ranganath T, Reyburn HT, Martínez-Piñeiro L, Blish C, Valés-Gómez M. Castellano E, et al. Front Immunol. 2022 Sep 15;13:970931. doi: 10.3389/fimmu.2022.970931. eCollection 2022. Front Immunol. 2022. PMID: 36189320 Free PMC article.
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation.
García-Cuesta EM, López-Cobo S, Álvarez-Maestro M, Esteso G, Romera-Cárdenas G, Rey M, Cassady-Cain RL, Linares A, Valés-Gómez A, Reyburn HT, Martínez-Piñeiro L, Valés-Gómez M. García-Cuesta EM, et al. Front Immunol. 2015 Jun 8;6:284. doi: 10.3389/fimmu.2015.00284. eCollection 2015. Front Immunol. 2015. PMID: 26106390 Free PMC article.
New paradigms in prostate cancer.
Álvarez-Maestro M, Gómez Rivas J. Álvarez-Maestro M, et al. Arch Esp Urol. 2019 Mar;72(2):95-97. Arch Esp Urol. 2019. PMID: 30855009 Free article. English.
Active surveillance in renal tumors: Clinical and oncological outcomes.
Bazan AA, Carrion DM, Rivas JG, Quesada-Olarte J, Quintana LM, Alvarez-Maestro M, Martínez-Piñeiro L. Bazan AA, et al. J Cancer Res Ther. 2021 Apr-Jun;17(2):414-419. doi: 10.4103/jcrt.JCRT_562_18. J Cancer Res Ther. 2021. PMID: 34121686 Free article.
117 results